CHRYSIN FLAVONOID ATTENUATES DORSAL PROSTATE HYPERPLASIA IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR)

A benign prostatic hyperplasia (BPH), characterized by an increase in the number of epithelial and stromal cells, is a disease with a high incidence and prevalence in men aged over 50 years. BPH symptoms generate high health costs and many of the available treatments cause side effects. In this sense, natural substances with therapeutic potential, such as chrysin, which has an antioxidant and androgenic effect, may be a new treatment alternative.